- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05270785
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care in Texas
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a cluster randomized study focused on youth suicide prevention which will recruit 40 youth from four primary care clinics serving sexual and gender diverse young adults in the Dallas and Austin, TX metropolitan areas. Each clinic will recruit 10 youth. Two clinics will be randomly assigned to deliver each of the two study interventions. The interventions are adapted versions of two existing, brief suicide prevention interventions: 1) Suicidal Teens Accessing Treatment after an ED Visit (STAT-ED) is a brief intervention based on motivational interviewing that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management; and 2) Youth-Nominated Support Team for Suicidal Adolescents (YST-II) is a brief intervention developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation. The revised interventions will be called STAT-PC and YST-III. For YST III, participants will identify 1-2 supportive adults from their lives who agree to provide ongoing contact and support. The interventions will last two months. Primary and secondary outcome assessments will be done at baseline and/or at 2 months.
To be eligible, participants must report risk factors for suicide based on screening questions that will be implemented in our primary clinic sites.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75390
- UT Southwestern Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- be aged 18-24 at the time of enrollment; and
- not have received mental health services in the past 90 days, excluding medication;
- English-speaking, and
- screen positive for suicidal ideation.
Exclusion Criteria:
- are actively suicidal
- have a developmental disability that would preclude them from participating in the study intervention or
- who are impaired due to psychosis, mania, or substance use that would prevent them from providing consent.
- Participants will also be excluded at YST-III sites if they are unable to identify a minimum of one support person to participate in the intervention with them.
Those who are excluded will be provided with referrals for treatment services.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Suicidal Teens Accessing Treatment - Primary Care (STAT-PC)
This group will undergo a brief, suicide prevention intervention based on motivational interviewing that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management
|
STAT-PC is an adapted version of Suicidal Teens Accessing Treatment after an ED Visit (STAT-ED).
It is a brief intervention based on motivational interviewing (MI) that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management (2-3 follow-up calls).
The intervention will consist of an initial session with the youth focusing on accessing mental health care plus two case management calls.
The interventionist will also be available to assist with referrals for connection to other services later during the study period as needed for up to two months.
The intervention may include contact with the youth's mental health provider to make sure linkages are made.
|
|
Experimental: Youth-Nominated Support Team (YST-III)
This group will undergo a brief, suicide prevention intervention originally developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation that has been adapted
|
YST-III is an adapted version of Youth-Nominated Support Team for Suicidal Adolescents (YST-II).
The intervention is a brief intervention developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation (SI).
Participants will nominate 1-2 supportive adults (age 18 and older) from their lives who agree to provide ongoing contact and support for up to 2 months.
YST-III will include an introductory session with the youth who will nominate their support persons plus referrals for mental health services.
The support persons will receive training on how to best support their youth partner and then ongoing calls to support them in working with their youth partner for up to 2 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in suicidal ideation as measured by ASIQ
Time Frame: Baseline, 2 months
|
Change in suicidal ideation is measured by Adult Suicidal Ideation Questionnaire (ASIQ).
It is a 25-item, self-report assessment of suicidal thoughts designed specifically for adult populations.
Possible scores range from 1 (Not at All) to 6 (Extreme), with lower scores indicating less severe suicidal ideation (better outcome)
|
Baseline, 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in number of mental healthcare service utilization as measured by ED-STARS mental health service utilization check list
Time Frame: Baseline, 2 months
|
Change in number of mental healthcare service utilization is measured by Emergency Department Screen for Teens at Risk for Suicide (ED-STARS) mental health service utilization check list which will be used to assess the number of different types of mental health services that participants receive including inpatient psychiatric services, emergency department visits, medication management, and psychotherapy/counseling.
|
Baseline, 2 months
|
|
Number of past 2 months suicide attempts at baseline
Time Frame: Baseline
|
Past 2 months suicide attempts is measured by suicide attempt question from the Columbia-Suicide Severity Rating Scale (CSSRS) which will assess the number of suicide attempts.
|
Baseline
|
|
Number of lifetime suicide attempts at baseline
Time Frame: Baseline
|
Suicide attempts is measured by suicide attempt question from the Columbia-Suicide Severity Rating Scale (CSSRS) which will assess the number of suicide attempts.
|
Baseline
|
|
Number of suicide attempts at 2 months
Time Frame: 2 months
|
Suicide attempts is measured by suicide attempt questions from the Columbia-Suicide Severity Rating Scale (CSSRS) which will assess the number of suicide attempts.
|
2 months
|
|
Change in depressive symptoms as measured by CESD-R
Time Frame: Baseline, 2 months
|
Change in depressive symptoms is measured by Center for Epidemiologic Studies Depression Scale-Revised (CESD-R) which is a 20-item measure of depression that assesses the duration symptoms across a period of two weeks.
Possible scores range from 0-60, with lower scores indicating less depressive symptoms (better outcome).
|
Baseline, 2 months
|
|
Change in social support as measured by MSPSS
Time Frame: Baseline, 2 months
|
Change in social support is measured by Multidimensional Scale of Perceived Social Support (MSPSS) which is a 12-item measure with three subscales that assesses family, friend, and significant other support.
Response categories are on a 7-point Likert-scale from 1=very strongly disagree to 7=very strongly agree.
The overall score will be used to assess change.
The 12-item MSPSS scale has a mean continuous score ranging from 1-84.
Higher scores indicate greater perceived social support (better outcome).
|
Baseline, 2 months
|
|
Change in internalized stigma as measured by ITS-adapted
Time Frame: Baseline, 2 months
|
Change in internalized stigma is measured by Internalized Transphobia Scale (ITS) - adapted.
Internalized stigma will be measured by an adapted version of the Internalized Transphobia Scale (ITS).
The measure consists of 22 questions.
Possible score ranges from 1-4 with lower scores indicating less internalized stigma (better outcome)
|
Baseline, 2 months
|
|
Number of deaths by suicide at 2 months
Time Frame: 2 months
|
The data on any reported deaths due to suicide during the study period will be collected.
|
2 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants who had access to means for suicide at baseline
Time Frame: Baseline
|
This is a descriptive measure with patient reported Yes/ No responses and if yes, to categorize the means for suicide.
|
Baseline
|
|
Number of participants who had access to means for suicide at 2 months
Time Frame: 2 months
|
This is a descriptive measure with patient reported Yes/ No responses and if yes, to categorize the means for suicide.
|
2 months
|
|
Proportion of participants who screened and met criteria
Time Frame: Last day of study recruitment period (approx. week 14)
|
Proportion of participants who screened and met criteria is obtained at the last day of the study recruitment period.
|
Last day of study recruitment period (approx. week 14)
|
|
Proportion of participants who enrolled in the study
Time Frame: Last day of study recruitment period (approx. week 14)
|
Proportion of participants who enrolled in the study is obtained at the last day of the study recruitment period.
|
Last day of study recruitment period (approx. week 14)
|
|
Number of participants who decide not to participate
Time Frame: 2 months post-intervention
|
For potential study candidates who decide not to participate, refusal reason will be logged.
|
2 months post-intervention
|
|
Intervention acceptability
Time Frame: 1 month post-intervention
|
Intervention acceptability will be measured by asking participants to rate the extent to which they agree with 4 statements about the study intervention received on a scale of 1 to 4 where 1 is strongly disagree and 4 is strongly agree
|
1 month post-intervention
|
|
Study feasibility
Time Frame: 1 month post-intervention
|
Study feasibility will be measured by asking participants to rate the extent to which they agree with 5 statements about the study on a scale of 1 to 4 where 1 is strongly disagree and 4 is strongly agree.
|
1 month post-intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Elizabeth Arnold, PhD, UT Southwestern Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU-2022-0351
- SP-2020C3-210 (Other Grant/Funding Number: PCORI)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicidal Ideation
-
Northwestern UniversityNot yet recruitingSuicidal Ideation and Behavior
-
University GhentRecruitingSuicide | Suicidal Ideation and Behavior | Crisis InterventionBelgium
-
Shira BarzilaySchneider Children's Medical Center, IsraelRecruiting
-
University of WashingtonUnited States Department of Defense; Military Suicide Research ConsortiumCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation ActiveUnited States
-
The Catholic University of AmericaUniversity of Washington; VA Office of Research and DevelopmentCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation Active
-
Emory UniversityGeorgia Institute of TechnologyCompletedSuicide, Suicidal IdeationUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH)RecruitingSuicidal Ideation and BehaviorUnited States
-
Bradley HospitalNational Institute of Mental Health (NIMH); Instituto Nacional de Psiquiatría...Not yet recruitingSuicidal Ideation/BehaviorMexico
-
Oriana Arellano FaúndezActive, not recruitingSuicidal Ideation | Suicidal Ideation and BehaviorsChile
-
VA Office of Research and DevelopmentJames J. Peters Veterans Affairs Medical Center; VISN 2 Mental Illness Research... and other collaboratorsRecruitingHealth | Reintegration Difficulties | Suicidal Ideation and Behaviors | ConnectednessUnited States
Clinical Trials on STAT-PC
-
Elizabeth ArnoldPatient-Centered Outcomes Research InstituteRecruitingSuicidal Ideation | SuicideUnited States
-
Abbott Point of CareCompleted
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Terminated
-
Great Ormond Street Hospital for Children NHS Foundation...UnknownHeart Defects, CongenitalUnited Kingdom
-
Vanderbilt UniversityTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institutes of Health (NIH)Completed
-
University of PittsburghCompleted
-
AdventHealthUniversity of South Florida; Yale University; Beth Israel Deaconess Medical Center and other collaboratorsActive, not recruitingAssessment, Self | CompetenceUnited States
-
Hospices Civils de LyonCompletedPsychoactive Substances ConsumersFrance
-
Emory UniversityAbbottRecruitingBrain Injuries | Head InjuryUnited States